Magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;trihydrate
(VEVZQDGATGBLIC-UHFFFAOYSA-N)
Structure
- SMILES
- COc1ccc2c(c1)nc([n-]2)S(=O)Cc1ncc(c(c1C)OC)C.COc1ccc2c(c1)nc([n-]2)S(=O)Cc1ncc(c(c1C)OC)C.O.O.O.[Mg+2]
- Molecular Formula:
- C34H42MgN6O9S2
- Molecular Weight:
- 767.167
- Log P:
- 6.5961
- Hydrogen Bond Acceptor:
- 13
- Hydrogen Bond Donor:
- 3
- TPSA:
- 214.51
- CAS Number(s):
- 217087-09-7
Synonym(s)
1.
Magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;trihydrate
2.
Esomeprazole magnesium trihydrate
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Epilepsy | FAERS: 1 | US FAERS | |
| 2 | Abdominal Pain | Canada Vigilance: 4 | Canada Vigilance | |
| 3 | Amyotrophic Lateral Sclerosis | Canada Vigilance: 2 | Canada Vigilance | |
| 4 | Ankle Fracture | Canada Vigilance: 2 | Canada Vigilance | |
| 5 | Atelectasis | Canada Vigilance: 1 | Canada Vigilance | |
| 6 | Biliary dilatation | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Chest Pain | Canada Vigilance: 3 | Canada Vigilance | |
| 8 | Dementia | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Dilatation intrahepatic duct acquired | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Diverticular perforation | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Drug ineffective | Canada Vigilance: 47 | Canada Vigilance | |
| 12 | Dyspepsia | Canada Vigilance: 10 | Canada Vigilance | |
| 13 | Eructation | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Expired product administered | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Flatulence | Canada Vigilance: 2 | Canada Vigilance | |
| 16 | Gastritis | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 18 | Hyperchlorhydria | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Hypophagia | Canada Vigilance: 1 | Canada Vigilance | |
| 20 | Intentional product misuse | Canada Vigilance: 1 | Canada Vigilance | |
| 21 | Intervertebral Disc Degeneration | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Malabsorption | Canada Vigilance: 4 | Canada Vigilance | |
| 23 | Malaise | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Nausea | Canada Vigilance: 1 | Canada Vigilance | |
| 25 | Osteopenia | Canada Vigilance: 4 | Canada Vigilance | |
| 26 | Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 27 | Palpitations | Canada Vigilance: 1 | Canada Vigilance | |
| 28 | Pneumonia | Canada Vigilance: 2 | Canada Vigilance | |
| 29 | Product compounding quality issue | Canada Vigilance: 1 | Canada Vigilance | |
| 30 | Product dose omission | Canada Vigilance: 1 | Canada Vigilance | |
| 31 | Product physical issue | Canada Vigilance: 1 | Canada Vigilance | |
| 32 | Product quality issue | Canada Vigilance: 5 | Canada Vigilance | |
| 33 | Product substitution issue | Canada Vigilance: 12 | Canada Vigilance | |
| 34 | Product use complaint | Canada Vigilance: 2 | Canada Vigilance | |
| 35 | Product use in unapproved indication | Canada Vigilance: 1 | Canada Vigilance | |
| 36 | Product use issue | Canada Vigilance: 2 | Canada Vigilance | |
| 37 | Reaction to excipient | Canada Vigilance: 1 | Canada Vigilance | |
| 38 | Thoracic vertebral fracture | Canada Vigilance: 2 | Canada Vigilance | |
| 39 | Urticaria | Canada Vigilance: 1 | Canada Vigilance | |
| 40 | kyphosis | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.